
|Articles|January 15, 2004
Inspire Pharmaceuticals to launch epinastine
Irvine, CA-Allergan Inc. and Inspire Pharmaceuticals Inc. will jointly promote epinastine HCl ophthalmic solution 0.05% (Elestat), with Inspire taking on primary duties for sales, promotion, and marketing.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Eyes on May 2026: A month of durable therapies, a regulatory reversal, and rethought echanisms
2
Reasoning prompts sharpen multimodal AI on bilingual ophthalmology exam questions
3
TECNIS PureSee IOL launches in US following FDA approval for cataract surgery
4
Beyond the Walls: Leading with love, loyalty, and a team first philosophy with Vance Thompson, MD
5





















